You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

parsaclisib

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma Trial in Shanghai (lenalidomide, rituximab, parsaclisib)

Not yet recruiting
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Ruijin hospital, school of medicine, Shanghai jiao tong universi
May 10, 2023

PI3Kd Inhibitor, Parsaclisib, CHOP Trial (Parsaclisib, CHOP)

Not yet recruiting
  • PI3Kδ Inhibitor
  • +3 more
  • (no location specified)
Feb 10, 2022

Follicular Lymphoma ( FL), Marginal Zone Lymphoma (MZL) Trial (parsaclisib, rituximab, obinutuzumab)

Withdrawn
  • Follicular Lymphoma ( FL)
  • Marginal Zone Lymphoma (MZL)
  • parsaclisib
  • +2 more
  • (no location specified)
Jul 14, 2022

Mantle Cell Lymphoma Trial (parsaclisib, rituximab, bendamustine)

Withdrawn
  • Mantle Cell Lymphoma
  • parsaclisib
  • +3 more
  • (no location specified)
Apr 22, 2022

Advanced Malignancies Trial in United States (parsaclisib)

Completed
  • Advanced Malignancies
  • parsaclisib
  • Tustin, California
  • +3 more
Aug 16, 2022

Peripheral T-Cell Lymphoma Trial in Zhengzhou (Parsaclisib, Chidamide)

Not yet recruiting
  • Peripheral T-Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Dec 26, 2021

Advanced Malignancies Trial in United States (parsaclisib)

Completed
  • Advanced Malignancies
  • parsaclisib
  • Rialto, California
  • +4 more
Mar 28, 2022

Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Primary Cutaneous

Recruiting
  • Recurrent Anaplastic Large Cell Lymphoma
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 6, 2022

Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma Trial in Japan (tafasitamab, lenalidomide, parsaclisib)

Recruiting
  • Non Hodgkins Lymphoma
  • Diffuse Large B-cell Lymphoma
  • Aichi, Japan
  • +4 more
Jan 24, 2022

Lymphoma Trial in Japan (Parsaclisib)

Active, not recruiting
  • Lymphoma
  • Parsaclisib
  • Aichi, Japan
  • +5 more
Jul 28, 2022

Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (tafasitamab, parsaclisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Lymphoma
  • Birmingham, Alabama
  • +49 more
Sep 21, 2022

Autoimmune Hemolytic Anemia Trial in Worldwide (Parsaclisib)

Active, not recruiting
Has Results
  • Autoimmune Hemolytic Anemia
  • Parsaclisib
  • Washington, District of Columbia
  • +11 more
Aug 26, 2022

Breast Cancer, Breast Tumors, Triple Negative Breast Cancer Trial (Parsaclisib)

Withdrawn
  • Breast Cancer
  • +3 more
  • Parsaclisib
  • (no location specified)
Nov 2, 2020

Primary Sjögren's Syndrome Trial in United States (Parsaclisib)

Completed
Has Results
  • Primary Sjögren's Syndrome
  • Parsaclisib
  • Miami, Florida
  • +3 more
Aug 11, 2021

Ann Arbor Stage II DLBCL, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma Trial in Scottsdale,

Recruiting
  • Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
  • +13 more
  • Scottsdale, Arizona
  • +2 more
Jun 1, 2022

Lymphoma Trial in Worldwide (Parsaclisib, Hexal, Gazyvaro)

Completed
  • Lymphoma
  • Parsaclisib
  • +2 more
  • Gilbert, Arizona
  • +20 more
Dec 1, 2021

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • parsaclisib
  • +2 more
  • Anchorage, Alaska
  • +172 more
Dec 1, 2022

Lymphoma Trial in Worldwide (Parsaclisib)

Active, not recruiting
Has Results
  • Lymphoma
  • Parsaclisib
  • Phoenix, Arizona
  • +82 more
Oct 14, 2022

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • parsaclisib
  • +2 more
  • Berkeley, California
  • +176 more
Dec 1, 2022

Lymphoma Trial in Worldwide (Parsaclisib)

Completed
Has Results
  • Lymphoma
  • Parsaclisib
  • Birmingham, Alabama
  • +69 more
Feb 28, 2022

Pemphigus Vulgaris Trial (Parsaclisib)

Withdrawn
  • Pemphigus Vulgaris
  • Parsaclisib
  • (no location specified)
Sep 11, 2019